PURE Bioscience, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
PURE Bioscience, Inc. (PURE) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$453.00 thousand for the 12-month period ending 2019-07-31, per its 10-K filed 2019-10-30.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2019-10-30
- PURE Bioscience, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2019 was -$453.00K.
- PURE Bioscience, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was -$789.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|
| 2019-07-31 | -$453.00K 10-K · filed 2019-10-30 | |
| 2019-04-30 | -$511.00K 10-Q · filed 2019-06-13 | |
| 2018-07-31 | -$789.00K 10-K · filed 2019-10-30 | |
| 2018-04-30 | -$622.00K 10-Q · filed 2019-06-13 |